Efficacy

First-time treatment success:* healthy patients, satisfied clients

Infographic: high single-injection success rates demonstrated in multiple studies

For patients with bacterial skin infections, you want to provide safe, continuous relief — with rapid speed of onset and first-time treatment success.

That relief also gives pet owners peace of mind. Ninety-six percent of pet owners said they would use CONVENIA® (cefovecin sodium) again if their veterinarian recommended it.5

A single injection offers:

  • Rapid speed of onset
    Clinical signs of infection may begin to show improvement within hours after an injection.
  • Duration of relief
    Provides up to 14 days of antibiotic therapy.3,4
  • Proven efficacy
    Gives your patients safe, effective treatment of common bacterial skin infections.3,4

In clinical studies:

  • Four safety and efficacy studies showed:
    A single 8 mg/kg (3.6 mg/lb) injection of cefovecin sodium was effective and safe in treating bacterial skin infections in dogs3,8,9 and cats.4
  • Additional pharmacokinetic studies in dogs1 and in cats2 showed:
    Cefovecin has the ideal pharmacokinetic-pharmacodynamic characteristics for time-dependent antimicrobial.
All clinical diagnoses in Dogs: Treatment Outcomes

Field efficacy studies in dogs & cats

In field efficacy studies, a single CONVENIA injection was clinically equivalent in efficacy to a 14-day course of an oral cephalosporin in treating bacterial skin infections in dogs3 and cats.4

Field efficacy study: dogs3

All clinical diagnoses in Dogs: Treatment Outcomes

Results

A single injection of CONVENIA at 8 mg/kg (3.6 mg/lb) administered subcutaneously, which could be repeated once after 14 days, was safe and effective against naturally occurring infections in dogs.

Study design

In a double-blind multicenter study of dogs diagnosed with naturally occurring skin infections:

  • 235 enrolled client-owned dogs were evaluated for efficacy.
  • Each infection was confirmed by bacterial culture.
  • Half of patients received saline injection followed by a 14-day course of cefadroxil.
  • Half of patients received CONVENIA followed by a 14-day course of placebo tablets.
  • A total of two 14-day treatment courses were permitted.
  • Dogs were evaluated on days 0, 7, 14 and 28 if administered 1 treatment course. If a second treatment was given of either CONVENIA or cefadroxil, dogs were also evaluated at day 42.

In a double-blind multicenter study of dogs diagnosed with naturally occurring skin infections:

  • 235 enrolled client-owned dogs were evaluated for efficacy.
  • Each infection was confirmed by bacterial culture.
  • Half of patients received saline injection followed by a 14-day course of cefadroxil.
  • Half of patients received CONVENIA followed by a 14-day course of placebo tablets.
  • A total of two 14-day treatment courses were permitted.
  • Dogs were evaluated on days 0, 7, 14 and 28 if administered 1 treatment course. If a second treatment was given of either CONVENIA or cefadroxil, dogs were also evaluated at day 42.

Field efficacy study: cats4

All clinical diagnoses in Cats: Treatment Outcomes

Results

A single injection of CONVENIA at 8 mg/kg (3.6 mg/lb) administered subcutaneously was safe and effective against naturally occurring infections in cats.

Study design

In a double-blind multicenter study of cats diagnosed with naturally occurring skin infections:

  • 291 cats were enrolled.
  • Each infection was confirmed by bacterial culture.
  • Half of patients received saline injection followed by a 14-day course of cefadroxil.
  • Half of patients received CONVENIA followed by a 14-day course of placebo tablets.
  • One 14-day treatment course was permitted.
  • Cats were evaluated on days 0, 7, 14 and 28.

In a double-blind multicenter study of dogs diagnosed with naturally occurring skin infections:

  • 291 cats were enrolled.
  • Each infection was confirmed by bacterial culture.
  • Half of patients received saline injection followed by a 14-day course of cefadroxil.
  • Half of patients received CONVENIA followed by a 14-day course of placebo tablets.
  • One 14-day treatment course was permitted.
  • Cats were evaluated on days 0, 7, 14 and 28.
View safety profile »
See CONVENIA case studies »